Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • gogodidi
    Junior Member
    • Aug 2012
    • 4

    #1

    RNASeq: Read length different from expected

    Hello all,

    I have received paired-end reads for 40 samples.
    The reads are supposed to be 100bp per end.
    Instead, 20 of my samples are 101bp per end, while the other 20 are 100bp as expected.

    Because of this, we assume that these 20 samples were all in the same lane; and that by accident there was an extra iteration in the illumina sequencing.
    However, we also see a strong negative correlation with read length and quality; the samples in which we had 101bp per end lose about 30% of the reads in the trimmomatic quality step.

    My question is: Has this happened to anyone else? Does it occur often, and if so, does it often affect quality? We are really quite puzzled by this.

    Any ideas / clues appreciated.

    Thank you!
    -Thies Gehrmann
  • mastal
    Senior Member
    • Mar 2009
    • 666

    #2
    RNASeq: Read length different from expected

    The read length of 101 bp instead of 100 bp would probably be because the operator thought there were enough reagents left to sequence the extra base.


    Presumably the run that gave the 101 bp reads had some problems that resulted in poorer base qualities than the run or lane that gave the 100 bp reads.

    Comment

    • GenoMax
      Senior Member
      • Feb 2008
      • 7142

      #3
      That is odd. I do not think one can set up lanes on a single flowcell to run for different number of cycles.

      Have you checked with your provider to confirm if all the samples ran together (were they multiplexed) or if there was a batch difference (2 separate runs?) that can account for your observation. I think it would probably be the latter case.

      Comment

      • mastal
        Senior Member
        • Mar 2009
        • 666

        #4
        The read identifiers for each sample should tell you if they were on the same flow cell or lane.

        Comment

        • GenoMax
          Senior Member
          • Feb 2008
          • 7142

          #5
          Originally posted by mastal View Post
          The read identifiers for each sample should tell you if they were on the same flow cell or lane.
          Great point. This should be easy to check.

          Comment

          • kmcarr
            Senior Member
            • May 2008
            • 1181

            #6
            It is somewhat standard practice for Illumina sequencing that if you want read lengths of N bases you run N+1 cycles. This has to do with the way base calling works on Illumina; to properly call the base at position n in a read you need data from cycle n+1. The last base in a read will always have a lower Q-score reflecting the added uncertainty in the base call. To mitigate this you run N+1 cycles but just report N bases per read, dropping the last, low quality base. This practice is ingrained in the Illumina run recipes; the standard PE100 recipe (with indexing) on the HiSeq runs a 209 cycles (101 + 7 + 101) adding an extra cycle each to read 1, the index read and read 2. (Interestingly the MiSeq recipes still add the extra cycle to reads 1 & 2 but not to the index read.)

            Some core labs simply call and report all 101 cycles, some stick to the original practice of clipping the last base. It may be that your samples were all run together on the same flow cell for 2x101 cycles but for one set of 20 they reported all 101 cycles and the other they clipped the last base. You need to check the IDs of your samples to identify the flow cell and lanes used for each.

            Comment

            • gogodidi
              Junior Member
              • Aug 2012
              • 4

              #7
              Originally posted by mastal View Post
              The read identifiers for each sample should tell you if they were on the same flow cell or lane.
              Indeed, they were!
              Thank you (Don't know why it didn't occur to me).

              Comment

              • gogodidi
                Junior Member
                • Aug 2012
                • 4

                #8
                Originally posted by kmcarr View Post
                It is somewhat standard practice for Illumina sequencing that if you want read lengths of N bases you run N+1 cycles. This has to do with the way base calling works on Illumina; to properly call the base at position n in a read you need data from cycle n+1. The last base in a read will always have a lower Q-score reflecting the added uncertainty in the base call. To mitigate this you run N+1 cycles but just report N bases per read, dropping the last, low quality base. This practice is ingrained in the Illumina run recipes; the standard PE100 recipe (with indexing) on the HiSeq runs a 209 cycles (101 + 7 + 101) adding an extra cycle each to read 1, the index read and read 2. (Interestingly the MiSeq recipes still add the extra cycle to reads 1 & 2 but not to the index read.)

                Some core labs simply call and report all 101 cycles, some stick to the original practice of clipping the last base. It may be that your samples were all run together on the same flow cell for 2x101 cycles but for one set of 20 they reported all 101 cycles and the other they clipped the last base. You need to check the IDs of your samples to identify the flow cell and lanes used for each.
                Thank you for this information.
                It is strange then, that they cut it for one lane, and not for the other.
                I'll have to call them to ask about that.

                Thank you so much, all of you!

                Comment

                Latest Articles

                Collapse

                • SEQadmin2
                  Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
                  by SEQadmin2



                  Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

                  Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
                  ...
                  10-14-2026, 09:55 AM
                • SEQadmin2
                  New Genomics Technologies Take Aim at Long-Standing Limits
                  by SEQadmin2


                  Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

                  We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
                  ...
                  09-28-2026, 10:25 AM

                ad_right_rmr

                Collapse

                News

                Collapse

                Topics Statistics Last Post
                Started by SEQadmin2, Yesterday, 11:13 AM
                0 responses
                16 views
                0 reactions
                Last Post SEQadmin2  
                Started by SEQadmin2, Yesterday, 10:48 AM
                0 responses
                17 views
                0 reactions
                Last Post SEQadmin2  
                Started by SEQadmin2, 10-15-2026, 10:52 AM
                0 responses
                35 views
                0 reactions
                Last Post SEQadmin2  
                Started by SEQadmin2, 10-14-2026, 05:39 AM
                0 responses
                42 views
                0 reactions
                Last Post SEQadmin2  
                Working...